All Articles on Coronavirus
Volunteers needed for COVID-19 booster trialNIAID-sponsored study includes Seattle in test for benefits of mixing different vaccine types.
COVID-19 vaccine well tolerated, generates immune responseNational Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
Making self-care videos in the age of pandemicMelissa Parson shares 4 lessons she learned while on assignment with Kaiser Permanente Washington diabetes nurses.
How epidemiologists predict the future of COVID-19KPWHRI’s Dr. Michael Jackson describes how better testing will improve our ability to forecast the pandemic’s path.
Coronavirus vaccine trial now includes older peopleLed by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
Research versus COVID-19From clinical trials to technical support, Dr. Rita Mangione-Smith describes how Kaiser Permanente Washington researchers are fighting the novel coronavirus.
Kaiser Permanente launches first coronavirus vaccine trialOn March 16, 4 volunteers received an injection of an mRNA vaccine for COVID-19 in NIH-funded trial in Seattle.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.